SNDX
Syndax Pharmaceuticals (SNDX)
$44
About Syndax Pharmaceuticals (SNDX)
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.
Details
Daily high
$13.76
Daily low
$13.23
Price at open
$13.76
52 Week High
$25.07
52 Week Low
$12.06
Market cap
1.2B
Dividend yield
0.00%
Volume
809,268
Avg. volume
1.9M
P/E ratio
-3.60
Syndax Pharmaceuticals News
Details
Daily high
$13.76
Daily low
$13.23
Price at open
$13.76
52 Week High
$25.07
52 Week Low
$12.06
Market cap
1.2B
Dividend yield
0.00%
Volume
809,268
Avg. volume
1.9M
P/E ratio
-3.60